RATTOTTI, SARA
RATTOTTI, SARA
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders
2019-01-01 Varettoni, M.; Zibellini, S.; Boveri, E.; Klersy, C.; Candido, C.; Rattotti, S.; Ferretti, V. V.; Defrancesco, I.; Mangiacavalli, S.; Nizzoli, M. E.; Flospergher, E.; Zerbi, C.; Bergamini, F.; Benvenuti, P.; Brociner, M.; Merati, G.; Paulli, M.; Arcaini, L.
Antibiotic therapy-induced remission of bladder mucosa-associated lymphoid tissue (MALT) lymphoma carrying t(11;18)(q21;q21) apoptosis inhibitor 2-MALT1.
2013-01-01 Lucioni, Marco; Nicola, Marta; Riboni, Roberta; Croci, Ga; Rattotti, Sara; Gotti, Manuel; Arcaini, Luca; Paulli, Marco; Cristina, S; Valentini, S; Martinengo, C.
Antiviral therapies for managing viral hepatitis in lymphoma patients
2017-01-01 Merli, Michele; Rattotti, Sara; Gotti, Manuel; Arcaini, Luca
Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy
2022-01-01 Colaneri, Marta; Pieri, Teresa Chiara; Roda, Silvia; Ricciardi, Alessandra; Gotti, Manuel; Ferrari, Jacqueline; Arcaini, Luca; Rattotti, Sara; Piralla, Antonio; Giardina, Federica; Ferrari, Guglielmo; Sacchi, Paolo; Zuccaro, Valentina; Baldanti, Fausto; Bruno, Raffaele
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry.
2010-01-01 Merli, Michele; Arcaini, Luca; Boveri, E; Rattotti, Sara; Picone, C; Passamonti, Francesco; Tenore, A; Sozzani, L; Lucioni, Marco; Varettoni, M; Rizzi, Silvia; Morello, L; Ferretti, V; Pascutto, C; Paulli, Marco; Lazzarino, Mario
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network
2019-01-01 Varettoni, M.; Boveri, E.; Zibellini, S.; Tedeschi, A.; Candido, C.; Ferretti, V. V.; Rizzo, E.; Doni, E.; Merli, M.; Farina, L.; Goldaniga, M.; Galli, A.; Rattotti, S.; Frustaci, A. M.; Deodato, M.; Bandiera, L.; Isimbaldi, G.; Uccella, S.; Cabras, A. D.; Gianelli, U.; Baldini, L.; Paulli, M.; Arcaini, L.
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi
2022-01-01 Merli, Michele; Rattotti, S.; Spina, M.; Re, F.; Motta, M.; Piazza, F.; Orsucci, L.; Ferreri, A. J. M.; Perbellini, O.; Dodero, A.; Vallisa, D.; Pulsoni, A.; Santoro, A.; Sacchi, P.; Zuccaro, V.; Chimienti, E.; Russo, Filomena; Visco, C.; Zignego, A. L.; Marcheselli, L.; Passamonti, F.; Luminari, S.; Paulli, M.; Bruno, R.; Arcaini, L.
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma.
2011-01-01 Arcaini, Luca; Varettoni, M; Boveri, E; Orlandi, E; Rattotti, Sara; Zibellini, S; Merli, Michele; Lucioni, Marco; Rizzi, Silvia; Gotti, Manuel; Morello, L; Pascutto, C; Paulli, Marco
Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study
2019-01-01 Luminari, S.; Merli, M.; Rattotti, S.; Tarantino, V.; Marcheselli, L.; Cavallo, F.; Varettoni, M.; Bianchi, B.; Merli, F.; Tedeschi, A.; Cabras, G.; Re, F.; Visco, C.; Delamain, M. T.; Cencini, E.; Spina, M.; Ferrero, S.; Ferrari, A.; Deodato, M.; Mannina, D.; Annibali, O.; Rago, A.; Orsucci, L.; Defrancesco, I.; Frigeni, M.; Cesaretti, M.; Arcaini, L.
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study
2023-01-01 Zuccaro, V.; Petazzoni, G.; Mileto, I.; Corbella, M.; Asperges, E.; Sacchi, P.; Rattotti, S.; Varettoni, M.; Defrancesco, I.; Cambieri, P.; Baldanti, F.; Arcaini, L.; Bruno, R.
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study
2023-01-01 Zuccaro, Valentina; Petazzoni, Greta; Mileto, Irene; Corbella, Marta; Asperges, Erika; Sacchi, Paolo; Rattotti, Sara; Varettoni, Marzia; Defrancesco, Irene; Cambieri, Patrizia; Baldanti, Fausto; Arcaini, Luca; Bruno, Raffaele
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network
2019-01-01 Rattotti, S.; Ferretti, V. V.; Rusconi, C.; Rossi, A.; Fogazzi, S.; Baldini, L.; Pioltelli, P.; Balzarotti, M.; Farina, L.; Ferreri, A. J. M.; Laszlo, D.; Speziale, V.; Varettoni, M.; Sciarra, R.; Morello, L.; Tedeschi, A.; Frigeni, M.; Defrancesco, I.; Zerbi, C.; Flospergher, E.; Nizzoli, M. E.; Morra, E.; Arcaini, L.
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL)
2019-01-01 Rusconi, C.; Anastasia, A.; Chiarenza, A.; Marcheselli, L.; Cavallo, F.; Rattotti, S.; Botto, B.; Ferrari, A.; Nassi, L.; Pagani, C.; Meli, E.; Arcaini, L.; Federico, M.; Rossi, G.
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers
2016-01-01 Lucioni, Marco; Berti, Emilio; Arcaini, Luca; Croci, GIORGIO ALBERTO; Maffi, Aldo; Klersy, Catherine; Goteri, Gaia; Tomasini, CARLO FRANCESCO; Quaglino, Pietro; Riboni, Roberta; Arra, Mariarosa; Dallera, Elena; Grandi, Vieri; Alaibac, Mauro; Ramponi, Antonio; Rattotti, Sara; Cabras, Maria Giuseppina; Franceschetti, Silvia; Fraternali Orcioni, Giulio; Zerbinati, Nicola; Onida, Francesco; Ascani, Stefano; Fierro, Maria Teresa; Rupoli, Serena; Gambacorta, Marcello; Zinzani, Pier Luigi; Pimpinelli, Nicola; Santucci, Marco; Paulli, Marco
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma.
2010-01-01 Zibellini, S; Capello, D; Forconi, F; Marcatili, P; Rossi, D; Rattotti, Sara; Franceschetti, S; Sozzi, E; Cencini, E; Marasca, R; Baldini, L; Tucci, A; Bertoni, F; Passamonti, Francesco; Orlandi, E; Varettoni, M; Merli, Michele; Rizzi, Silvia; Gattei, V; Tramontano, A; Paulli, Marco; Gaidano, G; Arcaini, Luca
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT.
2010-01-01 Paulli, Marco; Arcaini, Luca; Lucioni, Marco; Boveri, E; Capello, D; Passamonti, Francesco; Merli, Michele; Rattotti, Sara; Rossi, D; Riboni, Roberta; Berti, E.; Magrini, Umberto; Bruno, Raffaele; Gaidano, G; Lazzarino, Mario
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms
2012-01-01 Arcaini, Luca; Zibellini, S; Boveri, E; Riboni, Roberta; Rattotti, Sara; Varettoni, M; Guerrera, Ml; Lucioni, Marco; Tenore, A; Merli, Michele; Rizzi, Silvia; Morello, L; Cavalloni, C; Da Vià, Mc; Paulli, Marco; Cazzola, Mario
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients
2010-01-01 Arcaini, Luca; Merli, Michele; Passamonti, Francesco; Rizzi, Silvia; Ferretti, V; Rattotti, Sara; Pascutto, C; Paulli, Marco; Lazzarino, Mario
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
A risk-stratification model based on the initial concentration of the serum monoclonal protein and MYD88 mutation status identifies a subset of patients with IgM monoclonal gammopathy of undetermined significance at high risk of progression to Waldenström macroglobulinaemia or other lymphoproliferative disorders | 1-gen-2019 | Varettoni, M.; Zibellini, S.; Boveri, E.; Klersy, C.; Candido, C.; Rattotti, S.; Ferretti, V. V.; Defrancesco, I.; Mangiacavalli, S.; Nizzoli, M. E.; Flospergher, E.; Zerbi, C.; Bergamini, F.; Benvenuti, P.; Brociner, M.; Merati, G.; Paulli, M.; Arcaini, L. | |
Antibiotic therapy-induced remission of bladder mucosa-associated lymphoid tissue (MALT) lymphoma carrying t(11;18)(q21;q21) apoptosis inhibitor 2-MALT1. | 1-gen-2013 | Lucioni, Marco; Nicola, Marta; Riboni, Roberta; Croci, Ga; Rattotti, Sara; Gotti, Manuel; Arcaini, Luca; Paulli, Marco; Cristina, S; Valentini, S; Martinengo, C. | |
Antiviral therapies for managing viral hepatitis in lymphoma patients | 1-gen-2017 | Merli, Michele; Rattotti, Sara; Gotti, Manuel; Arcaini, Luca | |
Assessing the Efficacy of Early Therapies against SARS-CoV-2 in Hematological Patients: A Real-Life Study from a COVID-19 Referral Centre in Northern Italy | 1-gen-2022 | Colaneri, Marta; Pieri, Teresa Chiara; Roda, Silvia; Ricciardi, Alessandra; Gotti, Manuel; Ferrari, Jacqueline; Arcaini, Luca; Rattotti, Sara; Piralla, Antonio; Giardina, Federica; Ferrari, Guglielmo; Sacchi, Paolo; Zuccaro, Valentina; Baldanti, Fausto; Bruno, Raffaele | |
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. | 1-gen-2010 | Merli, Michele; Arcaini, Luca; Boveri, E; Rattotti, Sara; Picone, C; Passamonti, Francesco; Tenore, A; Sozzani, L; Lucioni, Marco; Varettoni, M; Rizzi, Silvia; Morello, L; Ferretti, V; Pascutto, C; Paulli, Marco; Lazzarino, Mario | |
Clinical and molecular characteristics of lymphoplasmacytic lymphoma not associated with an IgM monoclonal protein: A multicentric study of the Rete Ematologica Lombarda (REL) network | 1-gen-2019 | Varettoni, M.; Boveri, E.; Zibellini, S.; Tedeschi, A.; Candido, C.; Ferretti, V. V.; Rizzo, E.; Doni, E.; Merli, M.; Farina, L.; Goldaniga, M.; Galli, A.; Rattotti, S.; Frustaci, A. M.; Deodato, M.; Bandiera, L.; Isimbaldi, G.; Uccella, S.; Cabras, A. D.; Gianelli, U.; Baldini, L.; Paulli, M.; Arcaini, L. | |
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi | 1-gen-2022 | Merli, Michele; Rattotti, S.; Spina, M.; Re, F.; Motta, M.; Piazza, F.; Orsucci, L.; Ferreri, A. J. M.; Perbellini, O.; Dodero, A.; Vallisa, D.; Pulsoni, A.; Santoro, A.; Sacchi, P.; Zuccaro, V.; Chimienti, E.; Russo, Filomena; Visco, C.; Zignego, A. L.; Marcheselli, L.; Passamonti, F.; Luminari, S.; Paulli, M.; Bruno, R.; Arcaini, L. | |
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. | 1-gen-2011 | Arcaini, Luca; Varettoni, M; Boveri, E; Orlandi, E; Rattotti, Sara; Zibellini, S; Merli, Michele; Lucioni, Marco; Rizzi, Silvia; Gotti, Manuel; Morello, L; Pascutto, C; Paulli, Marco | |
Early progression as a predictor of survival in marginal zone lymphomas: An analysis from the FIL-NF10 study | 1-gen-2019 | Luminari, S.; Merli, M.; Rattotti, S.; Tarantino, V.; Marcheselli, L.; Cavallo, F.; Varettoni, M.; Bianchi, B.; Merli, F.; Tedeschi, A.; Cabras, G.; Re, F.; Visco, C.; Delamain, M. T.; Cencini, E.; Spina, M.; Ferrero, S.; Ferrari, A.; Deodato, M.; Mannina, D.; Annibali, O.; Rago, A.; Orsucci, L.; Defrancesco, I.; Frigeni, M.; Cesaretti, M.; Arcaini, L. | |
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study | 1-gen-2023 | Zuccaro, V.; Petazzoni, G.; Mileto, I.; Corbella, M.; Asperges, E.; Sacchi, P.; Rattotti, S.; Varettoni, M.; Defrancesco, I.; Cambieri, P.; Baldanti, F.; Arcaini, L.; Bruno, R. | |
Gut Microbiota and B Cell Receptor (BCR) Inhibitors for the Treatment of Chronic Lymphocytic Leukemia: Is Biodiversity Correlated with Clinical Response or Immune-Related Adverse Event Occurrence? A Cross-Sectional Study | 1-gen-2023 | Zuccaro, Valentina; Petazzoni, Greta; Mileto, Irene; Corbella, Marta; Asperges, Erika; Sacchi, Paolo; Rattotti, Sara; Varettoni, Marzia; Defrancesco, Irene; Cambieri, Patrizia; Baldanti, Fausto; Arcaini, Luca; Bruno, Raffaele | |
Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network | 1-gen-2019 | Rattotti, S.; Ferretti, V. V.; Rusconi, C.; Rossi, A.; Fogazzi, S.; Baldini, L.; Pioltelli, P.; Balzarotti, M.; Farina, L.; Ferreri, A. J. M.; Laszlo, D.; Speziale, V.; Varettoni, M.; Sciarra, R.; Morello, L.; Tedeschi, A.; Frigeni, M.; Defrancesco, I.; Zerbi, C.; Flospergher, E.; Nizzoli, M. E.; Morra, E.; Arcaini, L. | |
Outcome of transformed follicular lymphoma worsens according to the timing of transformation and to the number of previous therapies. A retrospective multicenter study on behalf of Fondazione Italiana Linfomi (FIL) | 1-gen-2019 | Rusconi, C.; Anastasia, A.; Chiarenza, A.; Marcheselli, L.; Cavallo, F.; Rattotti, S.; Botto, B.; Ferrari, A.; Nassi, L.; Pagani, C.; Meli, E.; Arcaini, L.; Federico, M.; Rossi, G. | |
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers | 1-gen-2016 | Lucioni, Marco; Berti, Emilio; Arcaini, Luca; Croci, GIORGIO ALBERTO; Maffi, Aldo; Klersy, Catherine; Goteri, Gaia; Tomasini, CARLO FRANCESCO; Quaglino, Pietro; Riboni, Roberta; Arra, Mariarosa; Dallera, Elena; Grandi, Vieri; Alaibac, Mauro; Ramponi, Antonio; Rattotti, Sara; Cabras, Maria Giuseppina; Franceschetti, Silvia; Fraternali Orcioni, Giulio; Zerbinati, Nicola; Onida, Francesco; Ascani, Stefano; Fierro, Maria Teresa; Rupoli, Serena; Gambacorta, Marcello; Zinzani, Pier Luigi; Pimpinelli, Nicola; Santucci, Marco; Paulli, Marco | |
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. | 1-gen-2010 | Zibellini, S; Capello, D; Forconi, F; Marcatili, P; Rossi, D; Rattotti, Sara; Franceschetti, S; Sozzi, E; Cencini, E; Marasca, R; Baldini, L; Tucci, A; Bertoni, F; Passamonti, Francesco; Orlandi, E; Varettoni, M; Merli, Michele; Rizzi, Silvia; Gattei, V; Tramontano, A; Paulli, Marco; Gaidano, G; Arcaini, Luca | |
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. | 1-gen-2010 | Paulli, Marco; Arcaini, Luca; Lucioni, Marco; Boveri, E; Capello, D; Passamonti, Francesco; Merli, Michele; Rattotti, Sara; Rossi, D; Riboni, Roberta; Berti, E.; Magrini, Umberto; Bruno, Raffaele; Gaidano, G; Lazzarino, Mario | |
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms | 1-gen-2012 | Arcaini, Luca; Zibellini, S; Boveri, E; Riboni, Roberta; Rattotti, Sara; Varettoni, M; Guerrera, Ml; Lucioni, Marco; Tenore, A; Merli, Michele; Rizzi, Silvia; Morello, L; Cavalloni, C; Da Vià, Mc; Paulli, Marco; Cazzola, Mario | |
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients | 1-gen-2010 | Arcaini, Luca; Merli, Michele; Passamonti, Francesco; Rizzi, Silvia; Ferretti, V; Rattotti, Sara; Pascutto, C; Paulli, Marco; Lazzarino, Mario |